SCHEMBL6212141

SCHEMBL6212141

Brc1cnc(Nc2ccc3[nH]cc(C4=CCNCC4)c3c2)nc1NCc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ HSD17B10 Q99714 2/20 0.43
▸ HTR2C P28335 2/20 0.43
▸ DRD2 P14416 1/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ CDK9 P50750 1/20 0.42
▸ HTR6 P50406 2/20 0.41
▸ PTK2 Q05397 3/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ HTR1D P28221 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ BRCA1 P38398 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ CDK1 P06493 3/20 0.40
▸ STAT6 P42226 1/20 0.40
▸ NTRK1 P04629 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6236688 0.94 PTK2 (0.42) KDM4EALDH1A1MAPTHSD17B10HTR2C
Trifluoroacetic Acid SCHEMBL6236987 0.93 NTRK1 (0.41) KDM4EALDH1A1MAPTHSD17B10HTR2C
SCHEMBL6241707 0.93 KDM4E (0.43) KDM4EALDH1A1MAPTHSD17B10HTR2C
SCHEMBL6236216 0.92 STK17B (0.42) KDM4EALDH1A1MAPTHSD17B10HTR2C
SCHEMBL6237654 0.92 KDM4E (0.42) KDM4EALDH1A1MAPTHSD17B10HTR2C
SCHEMBL6239654 0.92 CDK1 (0.44) KDM4EALDH1A1MAPTHSD17B10HTR2C
SCHEMBL6210939 0.92 HTR2C (0.42) KDM4EALDH1A1MAPTHSD17B10HTR2C
SCHEMBL6212597 0.92 NTRK1 (0.49) CDK9PTK2NTRK1
SCHEMBL6209598 0.92 PTK2 (0.44) KDM4EALDH1A1MAPTHSD17B10HTR2C
SCHEMBL6243567 0.91 TBK1 (0.43) KDM4EALDH1A1MAPTHSD17B10HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1578732-A2 PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH Pfizer Products Inc. (US) 2005-09-28 — — EP claimed
WO-2004056786-A2 PYRIMIDINE DERIVATES FOR THE TREATMENT OF ABNORMAL CELL GROWTH PFIZER PRODUCTS INC. (US) 2004-07-08 — — WO claimed
EP-1578732-A2 PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH Pfizer Products Inc. (US) 2005-09-28 — — EP disclosed
WO-2004056786-A2 PYRIMIDINE DERIVATES FOR THE TREATMENT OF ABNORMAL CELL GROWTH PFIZER PRODUCTS INC. (US) 2004-07-08 — — WO disclosed
Send feedback